Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-25

Clinical Trial Update: Early Combined Use of Dexamethasone Intravitreal Implant and Anti-VEGF in the Treatment of DME. [NA]

View source ↗

Summary

Update on a trial investigating early combined dexamethasone intravitreal implant with anti-VEGF therapy for diabetic macular edema; current status is active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ozurdex (dexamethasone intravitreal implant)
  • anti-VEGF therapy

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Diabetic Macular Edema (DME) | NA | Status: ACTIVE_NOT_RECRUITING